United Imaging Healthcare reported 2025 revenue up about 34% to roughly RMB 13.8 billion, with overseas revenue rising more than 50% and first-quarter 2026 revenue up around 17%, alongside continued R&D investment and portfolio expansion.
United Imaging Healthcare has reported strong financial results for 2025 and the first quarter of 2026, citing accelerating demand outside its home market. The company said 2025 revenue rose about 34% year on year to roughly RMB 13.8 billion, with net profit up around 48%. For the first quarter of 2026, it reported revenue of about RMB 2.91 billion, a gain of roughly 17% from a year earlier.
Overseas business was the standout, with international revenue climbing more than 50% in 2025 to about RMB 3.43 billion. The company said its installed base and service footprint now span more than 100 countries and regions, supported by regional service centers in 12 countries, 44 overseas service sites and dozens of spare-parts warehouses. In North America it reported over 640 system installations, while European revenue grew about 50% and Asia-Pacific markets grew more than 40%.
United Imaging also highlighted continued research investment of about RMB 2.62 billion in 2025 and a portfolio that now exceeds 150 products, including 75 CE-certified and 58 FDA-cleared systems and a new uSONIQUE ultrasound series. The results were released on April 29, 2026.
